Asston Pharmaceuticals Limited Press Release Jul 02 2026
Filed with BSE · · 4 pages · English
Subject: Outcome of Board Meeting Scrip Code: 544445 ISIN: INE0SJX01015 • Issue of up to 24,10,431 (Twenty-Four Lakh Ten Thousand Four Hundred and Thirty-One) Equity Shares having a face value of ₹10/- (Rupees Ten Only) each at an issue price of ₹115/- (Rupees One Hundred and Fifteen Only) per equity share, including a premium of ₹105/- (Rupees One Hundred and Five Only) per equity share, aggregat
Asston Pharmaceuticals Limited on 6ix
Earlier from Asston Pharmaceuticals
- Asston Pharmaceuticals Limited Press Release Jun 24 2026
- Asston Pharmaceuticals Limited Press Release Apr 28 2026
- Asston Pharmaceuticals Limited Press Release Apr 21 2026
- Asston Pharmaceuticals Limited Press Release Apr 06 2026
- Asston Pharmaceuticals Limited Press Release Mar 30 2026
Later from Asston Pharmaceuticals
- Asston Pharmaceuticals Limited Press Release Jul 14 2026
- Asston Pharmaceuticals Limited Press Release Jul 31 2026
- Asston Pharmaceuticals Limited Press Release Aug 31 2026
- Asston Pharmaceuticals Limited Press Release Sep 01 2026
- Asston Pharmaceuticals Limited Press Release Sep 04 2026
Follow Asston Pharmaceuticals into a list and get an email when it puts out news.
Follow Asston Pharmaceuticals